URGN
UroGen Pharma·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-03-28
Latest data update time: Updated on 2026-03-28
6.85 / 10Overall Score
OutperformInvestment Rating
6.85 / 10Overall Score
OutperformInvestment Rating
Trend Analysis of URGN
- Based on a composite score of 6.85/10, we rate URGN as a Outperform. Our analysis breaks down into 3.18/10 for Fundamentals, 6.16/10 for Technicals, and 9.02/10 for Sentiment, indicating the stock is likely to See further upside.
Technical Analysis of URGN?
Is URGN undervalued or overvalued?
Is money flowing into or out of URGN?
Trend Analysis of URGN
- Based on a composite score of 6.85/10, we rate URGN as a Outperform. Our analysis breaks down into 3.18/10 for Fundamentals, 6.16/10 for Technicals, and 9.02/10 for Sentiment, indicating the stock is likely to See further upside.
Is URGN undervalued or overvalued?
Technical Analysis of URGN?
Is money flowing into or out of URGN?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
